{
    "2018-11-23": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Pharma Stocks Soothe Stock-Market Malady",
                "features": {
                    "keywords": [
                        "Pharma",
                        "Stocks",
                        "Soothe",
                        "Stock-Market",
                        "Malady"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "These 3 Stocks Are Up 25% in 2018 -- Are They Still Buys?",
                "features": {
                    "keywords": [
                        "Stocks",
                        "Up",
                        "2018",
                        "Buys"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Pharma Stock Roundup: Cancer Approvals for PFE & ABBV, CHMP Nod for Several Drugs",
                "features": {
                    "keywords": [
                        "Pharma",
                        "Stock",
                        "Cancer",
                        "Approvals",
                        "PFE",
                        "ABBV",
                        "CHMP",
                        "Drugs"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Dow 30 Stock Roundup: Boeing to Supply 40 737 MAX 8 to Jeju Air, Pfizer Gets FDA Nod",
                "features": {
                    "keywords": [
                        "Dow",
                        "30",
                        "Stock",
                        "Boeing",
                        "737",
                        "MAX",
                        "Jeju",
                        "Air",
                        "Pfizer",
                        "FDA",
                        "Nod"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "aerospace",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-26",
                "original_text": "Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for November 26, 2018",
                "features": {
                    "keywords": [
                        "Johnson",
                        "&",
                        "Johnson",
                        "JNJ",
                        "Ex-Dividend",
                        "Date",
                        "Scheduled"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}